Notes - Finance Income And Finance Costs

Astellas Pharma Inc. - Filing #7258550

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Other
177,000,000 JPY
220,000,000 JPY
Finance income
7,874,000,000 JPY
11,455,000,000 JPY
Finance costs
Other
397,000,000 JPY
1,945,000,000 JPY
Finance costs
17,677,000,000 JPY
12,005,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.